Drug Topics

OCTOBER 10, 2022

A look at what’s to come in the October issue of Drug Topics®.

201

201

Fierce Pharma

APRIL 5, 2024

Amid ongoing drug shortages and other headline-grabbing issues that fall under the FDA’s purview, the House Committee on Oversight and Accountability is putting the agency’s commissioner Robert Cal | The April 11 hearing could be contentious, as the committee wants to “hold the commissioner accountable" for the FDA's action on drug shortages, (..)

FDA 94

FDA 94

pharmaphorum

MAY 1, 2024

Discover why capacity remains a critical issue in the industry. Explore the challenges in weight loss treatments despite the billions spent on clinical trials for weight loss drugs.

62

62

European Pharmaceutical Review

MARCH 1, 2024

This Issue was brought to you in partnership with Fujifilm Irvine Scientific: The post <em>European Pharmaceutical Review </em> Issue 1 2024 appeared first on European Pharmaceutical Review.

64

64

Pharmacy Times

JANUARY 3, 2023

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Communication 171

Communication 171

European Pharmaceutical Review

MARCH 11, 2024

The manufacturer Olympus Corporation has announced the rescission of an earlier acquisition deal due to reported data integrity issues of medical device products from Taewoong Medical Co., Data integrity issues The concerns around these products were found after the closing of the deal, Olympus noted. Up to $114.5

83

83

Drug Topics

MARCH 5, 2024

Health care professionals, industry leaders, and politicians gathered for a virtual roundtable to discuss the state of the PBM industry.

257

257

Fierce Healthcare

FEBRUARY 20, 2024

A year after hitting the pause button on a multi-billion-dollar health tech project at the Department of Veterans Affairs, federal lawmakers continue to have serious concerns about pharmacy softwar | A year after hitting the pause button on a multi-billion-dollar health tech project at the Department of Veterans Affairs, federal lawmakers continue (..)

Department of Veterans Affairs 109

Department of Veterans Affairs 109

Pharmaceutical Technology

MAY 2, 2024

Emerging research from the ESCMID Global 2024 conference suggests that antifungal resistance, a global issue, is on the rise.

52

52

Hospital Pharmacy Europe

APRIL 4, 2024

The importance of pharmacy professionals signposting children and young people experiencing gender identity issues such as gender incongruence or dysphoria to appropriate support services has been emphasised by the General Pharmaceutical Council (GPhC).

Hospitals 52

Hospitals 52

Fierce Pharma

APRIL 10, 2024

In a four-observation warning letter issued this week, the U.S. It usually goes without saying that your pharmaceutical production workers need to be gowned and gloved while handling drug materials inside clean rooms. |

FDA 90

FDA 90

STAT

APRIL 24, 2024

After months of deliberation, the Colombian government has issued a compulsory license for an HIV medicine, the first time the country has taken such a step, one that also marks a significant move in the increasingly global battle over access to medicines.

117

117

European Pharmaceutical Review

NOVEMBER 9, 2023

Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. We also explore opportunities for outsourcing of regulatory activities, the challenges of paediatric drug formulation and much more.

83

83

Pharma Marketing Network

JULY 26, 2023

However, in recent years, there has been a noticeable decline in the number of these letters being issued. Shifting Enforcement Priorities: One possible reason for the decrease in FDA-issued marketing violation letters is a shift in the agency’s enforcement priorities.

FDA 97

FDA Pharmaceutical Companies Pharmaceutical Companies Labelling 97

Pharmacy Times

OCTOBER 19, 2023

Latinx teens suffering with mental health issues are at risk of developing cardiovascular conditions in their future.

122

122

STAT

FEBRUARY 6, 2024

The Colombian government has taken a significant step toward issuing a compulsory license for a widely used HIV treatment, the latest instance in which cash-strapped governments battle with the pharmaceutical industry over the cost of medicines.

130

130

Drug Store News

AUGUST 10, 2023

Pharmacy legislation covering important issues, such as PBM reform and scope of practice, is gaining momentum at the state and federal levels. Here are the ones to watch.

98

98

European Pharmaceutical Review

FEBRUARY 21, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL (..)

103

103

DiversifyRx

SEPTEMBER 23, 2022

When you have owned a pharmacy long enough, pharmacy legal issues are bound to happen to you. . Types of Pharmacy Legal Issues for Pharmacy Owners. Unfortunately, I have experienced many of these issues myself. Each legal issue is unique. The post Pharmacy Legal Issues first appeared on DiversifyRx.

Independent Pharmacies 90

Independent Pharmacies FDA 90

Pharmaceutical Commerce

APRIL 3, 2024

Click the title above for a link to open the Pharmaceutical Commerce April 2024 issue in an interactive PDF format.

52

52

European Pharmaceutical Review

SEPTEMBER 4, 2023

Included in Issue 4 of European Pharmaceutical Review : FOREWORD Dissolution testing – a dual role David Elder, David P Elder Consultancy REGULATORY INSIGHT EU packaging reform: a prescription for change?

Packaging 81

Packaging Vaccines Immunization 81

European Pharmaceutical Review

APRIL 24, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD New quality requirements for tobacco products David Elder, David P Elder Consultancy QA/QC MASS SPECTROMETRY The benefits of mass spectrometry for expediting biologics to patients Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza IN-DEPTH FOCUS: Bioprocessing/Bioproduction Realising (..)

94

94

European Pharmaceutical Review

JUNE 27, 2023

Included in this issue of European Pharmaceutical Review : FOREWORD Nitrosamines: the beginning of the end? Elizabethann Wright, Cooley LLP The post <em>European Pharmaceutical Review</em> Issue 3 2023 appeared first on European Pharmaceutical Review.

Vaccines 89

Vaccines Immunization 89

BioPharm

MAY 17, 2023

The agency’s safety committee is reviewing hydroxyprogesterone medicines and issuing a reminder on safety issues regarding fluoroquinolone antibiotics.

98

98

STAT

OCTOBER 3, 2023

In the latest battle over access to medicines, Colombian authorities have decided to issue a compulsory license for a needed HIV treatment, a step that underscores ongoing friction between the pharmaceutical industry and cash-strapped governments around the world. Continue to STAT+ to read the full story…

122

122

Pharmacy Times

SEPTEMBER 7, 2023

Christina Madison, PharmD, FCCP, AAHIVP, speaks with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and patient access.

73

73

STAT

AUGUST 22, 2023

  FDA greenlights device to combat bladder issues Read the rest… You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.    Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday. 

FDA 88

FDA 88

pharmaphorum

NOVEMBER 2, 2023

Novo Nordisk shrugs off supply issues with record sales Phil.Taylor Thu, 02/11/2023 - 11:17 Bookmark this

99

99

Fierce Pharma

JANUARY 9, 2024

But the Japanese company will have to clear up manufacturing issues first. The FDA has sent a complete response letter to Astellas, rejecting zolbetuximab because of unresolved deficiencies identified in a pre-license inspection of a third-party manufacturing facility.

FDA 89

FDA 89

Drug Topics

JANUARY 3, 2023

A look at what’s to come in the January issue of Drug Topics®.

98

98

Drug Store News

DECEMBER 14, 2023

Drug Store News held its 25th annual Industry Issues Summit in New York City on Dec. 13, where industry leaders weighed in on a myriad of challenges and opportunities.

115

115

STAT

OCTOBER 19, 2023

RNA medicines startup Laronde is merging with another startup in the wake of a scientific misconduct issue that affected its leading drug candidates. Laronde was founded by biotech creation firm Flagship Pioneering in 2017 to develop a new type of genetic medicine called endless RNA.

126

126

Drug Topics

DECEMBER 1, 2022

A look at what’s to come in the December issue of Drug Topics®.

98

98

European Pharmaceutical Review

AUGUST 24, 2022

Included in this issue: NITROSAMINES. The post European Pharmaceutical Review Issue 4 2022 appeared first on European Pharmaceutical Review. Risks presented by active pharmaceutical ingredient nitrosamines. David Elder, David P Elder Consultancy. ENVIRONMENTAL MONITORING. Hannah Balfour with comment from Mike Russ at Genentech.

93

93

Drug Topics

NOVEMBER 1, 2022

A look at what’s to come in the November issue of Drug Topics®.

98

98

Pharmaceutical Commerce

JUNE 28, 2023

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues impacting broader supply chains.

92

92

STAT

DECEMBER 27, 2023

The fundamental issues and intriguing stories that characterized the year gone by will to continue to loom. So once again, we will take a whack at identifying some of the most noteworthy developments to watch. However, if these seem familiar, there is good reason.

Insurance 83

Insurance 83